AC

Acadia Healthcare Company, Inc.

ACHCHealthcareNASDAQ

Medical Care Facilities · Last scanned Jul 18, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$3.31B
+5.0% YoY
Net Income
-$1.10B
-531.4% YoY
EBITDA
-$737.8M
-221.4% YoY
Free Cash Flow
-$216.9M

Scan Results

Daily timeframe
6 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11 RSI OverboughtRSI 76.7, above 70, stock may be overbought
Jul 10 RSI OverboughtRSI 79.8, above 70, stock may be overbought
About Acadia Healthcare Company, Inc.

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. At a $3.17B market cap, Acadia Healthcare Company, Inc. ranks as a mid-cap company within healthcare. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Key stats
Market Cap$3.17B
Fwd P/E19.64
EPS$-12.52
Beta0.64
52W Change+57.4%
ROE-41.0%
Analysis

Acadia Healthcare Company, Inc. carries $2.69B in total debt against $158.5M in cash reserves — debt is roughly 17.0x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow is running at -$216.9M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of -41.0% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 4.2% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $2.61B (2022) to $3.31B (2025), reflecting a 27% increase over the period.

ACHC's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. Acadia Healthcare Company, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. No single metric tells the full story. Reviewing ACHC's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms